Ekso Bionics Shares Rise After FDA Clearance to Market its EksoNR™ Robotic Exoskeleton
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) shares spiked more than 20% on Monday after the Company announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its EksoNR™ robotic exoskeleton for use with Multiple...